5-75360714-T-C

Variant summary

Our verdict is Benign. Variant got -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_000859.3(HMGCR):​c.*372T>C variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.379 in 176,380 control chromosomes in the GnomAD database, including 13,341 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as drug response (no stars).

Frequency

Genomes: 𝑓 0.37 ( 11234 hom., cov: 32)
Exomes 𝑓: 0.41 ( 2107 hom. )

Consequence

HMGCR
NM_000859.3 3_prime_UTR

Scores

2

Clinical Significance

drug response no assertion criteria provided O:1

Conservation

PhyloP100: -0.166
Variant links:
Genes affected
HMGCR (HGNC:5006): (3-hydroxy-3-methylglutaryl-CoA reductase) HMG-CoA reductase is the rate-limiting enzyme for cholesterol synthesis and is regulated via a negative feedback mechanism mediated by sterols and non-sterol metabolites derived from mevalonate, the product of the reaction catalyzed by reductase. Normally in mammalian cells this enzyme is suppressed by cholesterol derived from the internalization and degradation of low density lipoprotein (LDL) via the LDL receptor. Competitive inhibitors of the reductase induce the expression of LDL receptors in the liver, which in turn increases the catabolism of plasma LDL and lowers the plasma concentration of cholesterol, an important determinant of atherosclerosis. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2008]
CERT1 (HGNC:2205): (ceramide transporter 1) This gene encodes a kinase that specifically phosphorylates the N-terminal region of the non-collagenous domain of the alpha 3 chain of type IV collagen, known as the Goodpasture antigen. Goodpasture disease is the result of an autoimmune response directed at this antigen. One isoform of this protein is also involved in ceramide intracellular transport. Three transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.533 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
HMGCRNM_000859.3 linkuse as main transcriptc.*372T>C 3_prime_UTR_variant 20/20 ENST00000287936.9 NP_000850.1 P04035-1A0A024RAP2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
HMGCRENST00000287936.9 linkuse as main transcriptc.*372T>C 3_prime_UTR_variant 20/201 NM_000859.3 ENSP00000287936.4 P04035-1

Frequencies

GnomAD3 genomes
AF:
0.373
AC:
56748
AN:
151946
Hom.:
11228
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.246
Gnomad AMI
AF:
0.386
Gnomad AMR
AF:
0.394
Gnomad ASJ
AF:
0.468
Gnomad EAS
AF:
0.533
Gnomad SAS
AF:
0.551
Gnomad FIN
AF:
0.452
Gnomad MID
AF:
0.329
Gnomad NFE
AF:
0.405
Gnomad OTH
AF:
0.369
GnomAD4 exome
AF:
0.413
AC:
10038
AN:
24316
Hom.:
2107
Cov.:
0
AF XY:
0.419
AC XY:
5229
AN XY:
12488
show subpopulations
Gnomad4 AFR exome
AF:
0.249
Gnomad4 AMR exome
AF:
0.396
Gnomad4 ASJ exome
AF:
0.469
Gnomad4 EAS exome
AF:
0.542
Gnomad4 SAS exome
AF:
0.536
Gnomad4 FIN exome
AF:
0.449
Gnomad4 NFE exome
AF:
0.398
Gnomad4 OTH exome
AF:
0.388
GnomAD4 genome
AF:
0.373
AC:
56781
AN:
152064
Hom.:
11234
Cov.:
32
AF XY:
0.380
AC XY:
28244
AN XY:
74330
show subpopulations
Gnomad4 AFR
AF:
0.247
Gnomad4 AMR
AF:
0.394
Gnomad4 ASJ
AF:
0.468
Gnomad4 EAS
AF:
0.533
Gnomad4 SAS
AF:
0.550
Gnomad4 FIN
AF:
0.452
Gnomad4 NFE
AF:
0.405
Gnomad4 OTH
AF:
0.367
Alfa
AF:
0.402
Hom.:
23154
Bravo
AF:
0.359
Asia WGS
AF:
0.523
AC:
1814
AN:
3478

ClinVar

Significance: drug response
Submissions summary: Other:1
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

Statins, attenuated cholesterol lowering by Other:1
drug response, no assertion criteria providedresearchDepartment of Cardiology, Chinese Academy of Medical Sciences, Fuwai HospitalNov 01, 2022- poor metabolizer

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
1.8
DANN
Benign
0.61

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs12916; hg19: chr5-74656539; API